September 18, 2018 – Washington, DC – Today, Friends of Cancer Research (Friends) announced the launch of Phase II of its tumor mutational burden or TMB Harmonization Project as the TMB harmonization team finalizes data collected from the Phase I in silico analysis. “Recent data shows a role for TMB in identifying patients more likely…
August 9, 2018 – WASHINGTON, D.C. – The American Society of Clinical Oncology, Inc. (ASCO®) and Friends of Cancer Research (Friends) have submitted to the Food and Drug Administration (FDA) recommended language for five guidance documents on ways to broaden eligibility criteria for cancer clinical trials. The recommendations are part of an ASCO and Friends…
New Data Supporting Use of Real-World Evidence Presented with Six Data Partners as well as FDA July 10, 2018 – Washington, DC – Today, Friends of Cancer Research (Friends) released the results of a unique pilot project at its event, The Future Use of Real-World Evidence. Data was compiled from six data partners regarding patients…
June 11, 2018 – Washington, DC – On Friday, June 8, 2018, The New York Times published an editorial titled “Easier Drug Approval Isn’t Cutting Drug Prices.” In it, The Times Editorial Board claims the FDA is lowering standards by working to get treatments to patients more quickly and instituting a “less regulation” approach to…
“Cancer patients cannot afford logistical delays and the OCE was not established to add another layer of bureaucracy.” – Ellen Sigal Washington, DC – March 14, 2018 – On Thursday, March 15, 2018, the U.S. Food and Drug Administration (FDA) will hold a public listening session on the Oncology Center of Excellence (OCE) from 9am…
WASHINGTON, DC, November 13, 2017 – Today, President Trump nominated Alex Azar to be the next Health and Human Services (HHS) Secretary. As the former head of one of our nation’s largest employers, Azar understands the multifaceted challenges that a Secretary may face. He previously served as Deputy HHS Secretary and HHS Chief Counsel under…
Friends Applauds Senate for FDA User Fee Bill Passage; Urges President Trump to Quickly Sign Into Law Washington, DC – August 3, 2017 – Friends of Cancer Research (Friends) applauds the Senate for voting overwhelmingly (94-1) today to pass the FDA Reauthorization Act of 2017 (H.R. 2430). The bill will now go to President Trump…
Friends of Cancer Research Applauds This Nomination Washington, DC – June 14, 2017 – President Donald Trump has nominated Dr. Norman E. Sharpless to be the next director at the National Cancer Institute (NCI). He will be replacing acting director Dr. Doug Lowy at the largest division within the National Institutes of Health. “We would…
Amendment Provides Opportunity for Patients to More Easily Gain Access to Potentially Beneficial Experimental Therapies While in Development Friends of Cancer Research (Friends) would like to thank and applaud the work of Senators Orrin Hatch (R-UT), Michael Bennet (D-CO), Richard Burr (R-NC), and Bob Casey (D-PA) who once again showed their tireless commitment to patients…
Washington, DC, April 27, 2017 – Friends of Cancer Research (Friends) would like to thank Chairman Alexander and the Senate HELP Committee for voting to report Dr. Scott Gottlieb’s nomination to be FDA commissioner favorably to the full Senate for a vote. The committee vote was 14-9 in favor of moving the nomination forward. …
